• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

穿孔素和颗粒酶B作为心脏移植急性排斥反应的标志物

Perforin and granzyme B as markers for acute rejection in heart transplantation.

作者信息

Clément M V, Haddad P, Soulié A, Benvenuti C, Lichtenheld M G, Podack E R, Sigaux N, Sasportes M

机构信息

INSERM U 93, Hôpital St Louis, Paris, France.

出版信息

Int Immunol. 1991 Nov;3(11):1175-81. doi: 10.1093/intimm/3.11.1175.

DOI:10.1093/intimm/3.11.1175
PMID:1760412
Abstract

Histological analysis of endomyocardial biopsies (EMB) is regarded as the most satisfactory technique for monitoring crisis of rejection in heart transplanted patients. In this study, 42 biopsies from 14 patients who underwent heart transplantation were examined. Three patients did not present any rejection crisis at the date of the biopsy analysis, six were examined during an early rejection crisis (day 7-70 post-graft), and five were examined during a late rejection crisis (day 74-960 post-graft). Since granzyme B and perforin are proteins associated with cell lysis histological grading and cell phenotype analysis, in situ hybridization using granzyme B and perforin [35S]RNA probes was performed on 30 EMB to characterize the cytolytic activation of heart infiltrating cells. Our data suggest that granzyme B and perforin could be used as predictive markers for acute rejection in patients with early rejection crisis. Their detection might be an indication to administrate corticoids to resolve an acute rejection crisis. In contrast, their absence in patients with late rejection crisis appears as a good prognostic factor for the outcome of rejection and raises the question of the necessity to treat such patients with additional corticoid treatment.

摘要

心内膜心肌活检(EMB)的组织学分析被认为是监测心脏移植患者排斥反应危象最令人满意的技术。在本研究中,对14例接受心脏移植患者的42份活检样本进行了检查。3例患者在活检分析时未出现任何排斥反应危象,6例在早期排斥反应危象期间(移植后7 - 70天)接受检查,5例在晚期排斥反应危象期间(移植后74 - 960天)接受检查。由于颗粒酶B和穿孔素是与细胞溶解组织学分级和细胞表型分析相关的蛋白质,因此使用颗粒酶B和穿孔素[35S]RNA探针进行原位杂交,对30份EMB进行检测,以表征心脏浸润细胞的溶细胞激活情况。我们的数据表明,颗粒酶B和穿孔素可作为早期排斥反应危象患者急性排斥反应的预测标志物。它们的检测可能提示应给予皮质类固醇以解决急性排斥反应危象。相比之下,晚期排斥反应危象患者中未检测到它们似乎是排斥反应预后良好的一个因素,并引发了是否有必要对这类患者进行额外皮质类固醇治疗的问题。

相似文献

1
Perforin and granzyme B as markers for acute rejection in heart transplantation.穿孔素和颗粒酶B作为心脏移植急性排斥反应的标志物
Int Immunol. 1991 Nov;3(11):1175-81. doi: 10.1093/intimm/3.11.1175.
2
Perforin and granzyme B: predictive markers for acute GVHD or cardiac rejection after bone marrow or heart transplantation.穿孔素和颗粒酶B:骨髓或心脏移植后急性移植物抗宿主病或心脏排斥反应的预测标志物。
Nouv Rev Fr Hematol (1978). 1991;33(6):465-70.
3
Granzyme A and perforin as markers for rejection in cardiac transplantation.颗粒酶A和穿孔素作为心脏移植排斥反应的标志物。
Eur J Immunol. 1991 Mar;21(3):687-93. doi: 10.1002/eji.1830210322.
4
Granzyme B and perforin can be used as predictive markers of acute rejection in heart transplantation.颗粒酶B和穿孔素可作为心脏移植急性排斥反应的预测标志物。
Eur J Immunol. 1994 Jan;24(1):229-33. doi: 10.1002/eji.1830240136.
5
Immunoexpression of perforin and granzyme B on infiltrating lymphocytes in human renal acute allograft rejection.穿孔素和颗粒酶B在人肾急性移植排斥反应中浸润淋巴细胞上的免疫表达
Nefrologia. 2003 Nov-Dec;23(6):538-44.
6
The relationship of granzyme A and perforin expression to cardiac allograft rejection and dysfunction.
Transplantation. 1995 Dec 27;60(12):1478-85. doi: 10.1097/00007890-199560120-00019.
7
The effect of cyclosporine treatment on the expression of genes encoding granzyme A and perforin in the infiltrate of mouse heart transplants.
Transplantation. 1993 Jan;55(1):139-45. doi: 10.1097/00007890-199301000-00026.
8
Intragraft activation of genes encoding cytotoxic T lymphocyte effector molecules precedes the histological evidence of rejection in human cardiac transplantation.在人类心脏移植中,编码细胞毒性T淋巴细胞效应分子的基因在移植物内的激活先于排斥反应的组织学证据出现。
Transplantation. 2001 Nov 27;72(10):1705-8. doi: 10.1097/00007890-200111270-00025.
9
[Perforin and granzyme B expression in liver allograft rejection].[肝移植排斥反应中穿孔素和颗粒酶B的表达]
Zhonghua Gan Zang Bing Za Zhi. 2004 Jun;12(6):325-7.
10
Expression of granzyme A and perforin in mouse heart transplants immunosuppressed with donor-specific transfusion and anti-CD4 monoclonal antibody.颗粒酶A和穿孔素在经供体特异性输血和抗CD4单克隆抗体免疫抑制的小鼠心脏移植中的表达
Transplantation. 1996 Feb 27;61(4):625-9. doi: 10.1097/00007890-199602270-00018.

引用本文的文献

1
Perforin: An intriguing protein in allograft rejection immunology (Review).穿孔素:同种异体移植排斥免疫学中一种引人关注的蛋白质(综述)。
Exp Ther Med. 2022 Jun 15;24(2):519. doi: 10.3892/etm.2022.11446. eCollection 2022 Aug.
2
Elevation of IGF-2 receptor and the possible underlying implications in end-stage heart failure patients before and after heart transplantation.IGF-2 受体水平在心脏移植前后终末期心力衰竭患者中的升高及其可能的潜在影响。
J Cell Mol Med. 2012 May;16(5):1038-46. doi: 10.1111/j.1582-4934.2011.01414.x.
3
Genotypic variation and phenotypic characterization of granzyme B gene polymorphisms.
颗粒酶B基因多态性的基因型变异与表型特征
Transplantation. 2009 Jun 27;87(12):1801-6. doi: 10.1097/TP.0b013e3181a755a4.
4
Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation.定量检测免疫激活转录本作为肾移植的诊断工具
Proc Natl Acad Sci U S A. 1997 Jan 21;94(2):695-700. doi: 10.1073/pnas.94.2.695.
5
Elafin, a serine elastase inhibitor, attenuates post-cardiac transplant coronary arteriopathy and reduces myocardial necrosis in rabbits afer heterotopic cardiac transplantation.弹性蛋白酶抑制因子(一种丝氨酸弹性蛋白酶抑制剂)可减轻心脏移植术后冠状动脉病变,并减少兔异位心脏移植后的心肌坏死。
J Clin Invest. 1996 Jun 1;97(11):2452-68. doi: 10.1172/JCI118692.
6
Increased expression of perforin and granzyme B genes in patients with metastatic melanoma treated with recombinant interleukin-2.重组白细胞介素-2治疗的转移性黑色素瘤患者中穿孔素和颗粒酶B基因表达增加。
Cancer Immunol Immunother. 1994 Jul;39(1):53-8. doi: 10.1007/BF01517181.